The Clorox Company (NYSE:CLX) Stake Lessened by Certuity LLC

Certuity LLC decreased its holdings in shares of The Clorox Company (NYSE:CLXFree Report) by 5.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,312 shares of the company’s stock after selling 189 shares during the quarter. Certuity LLC’s holdings in Clorox were worth $538,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of CLX. Brooklyn Investment Group increased its stake in Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares during the period. Prospera Private Wealth LLC purchased a new position in shares of Clorox during the 3rd quarter valued at $27,000. Continuum Advisory LLC increased its stake in shares of Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares during the last quarter. Carolina Wealth Advisors LLC acquired a new stake in Clorox during the third quarter valued at $48,000. Finally, Friedenthal Financial acquired a new stake in Clorox during the third quarter valued at $49,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Up 0.2 %

Shares of CLX stock opened at $148.66 on Thursday. The stock has a 50 day moving average of $160.30 and a 200-day moving average of $159.26. The firm has a market cap of $18.40 billion, a PE ratio of 40.62, a price-to-earnings-growth ratio of 2.52 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the firm posted $2.16 earnings per share. On average, equities analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.28%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 133.33%.

Analyst Ratings Changes

A number of research firms have recently weighed in on CLX. Evercore ISI raised their price target on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Barclays lifted their target price on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. DA Davidson reduced their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Finally, TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and increased their target price for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $158.21.

Get Our Latest Analysis on CLX

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.